Skip to content
  • Home
  • About
  • Team
  • Portfolio
  • News
  • Contact Us

Category: Uncategorized

January 2, 2023

Welcome to Alon Medtech Ventures newest portfolio company, Supra Medical!

Great news to start 2023! Welcome to Alon Medtech Ventures newest portfolio company, Supra Medical! Supra Medical is developing an innovative in office-guided opthalmic system for drug delivery.     Meet Supra's team here: https://www.linkedin.com/feed/update/urn:li:activity:7018138148941537280

Read More
December 20, 2022

Sofwave Medical Announces FDA Clearance of SUPERB™ Technology For Cellulite

SUPERB™ ANNOUNCEMENT! Sofwave™ has reached a new PEAK by receiving the U.S. Food and Drug Administration (FDA) clearance of an additional momentous indication for Sofwave's SUPERB™ technology to be used for the short-term improvement in the appearance of cellulite. "We are pleased to receive FDA clearance to use the Company's proprietary SUPERB™ technology to improve…

Read More
December 5, 2022

Levron Cardiovascular has been chosen as a finalist in the ICI 2022 startup and innovation competition

Congratulations to Levron Cardiovascular Ltd, an ICI Innovation Award Finalists, on an enlightening presentation! Meir Kenigsztein presented Levron, an Alon Medtech portfolio company, and it’s groundbreaking technology for the first time in front of a captive audience.   https://www.linkedin.com/posts/alon-medtech-ventures_ici2022-medtech-innovation-activity-7006188444141936640-rEGf?utm_source=share&utm_medium=member_desktop

Read More
December 3, 2022

Dr. Shimon Eckhouse received the Founders Choice & Committee Award at the Safety in Beauty Awards 2022 in London

Excited to share that Alon Medtech’s Chairman, Dr. Shimon Eckhouse received the Founders Choice & Committee Award at the Safety in Beauty Awards 2022 in London, celebrating his many accomplishments in the field! Congrats to Sofwave as well on receiving the UK Pioneering & Innovation Award. From the event: https://www.linkedin.com/posts/alon-medtech-ventures_innovation-medtech-vc-activity-7007985577069309952-mX-8?utm_source=share&utm_medium=member_desktop

Read More
November 10, 2022

"Click Chemistry" Concept Inspires BiOLinkMatrix by HALLURA™: the Next Generation of HA Dermal Fillers

Harnessing the 2022 Nobel Prize Awarded Click Chemistry Concept, Hallura's Products Revolutionize the Way Hyaluronic Acid is Crosslinked in Dermal Fillers Hallura Ltd., an Israeli aesthetic medical company, announced today that its proprietary technology named the BiOLinkMatrix platform was inspired by the 2022 Nobel Prize for Click Chemistry. Harnessing this concept, Hallura's products revolutionize the…

Read More
August 20, 2022

David Rainis, CEO of Jubaan presented at "THE PITCH" a leading startup competition in Israel hosted by EY 

Proud to share "The Pitch" by David ダビデ Rainis , Founder & CEO of Jubaan , our portfolio company. David presented as a Semi-finalist of "THE PITCH" the leading startup competition in Israel, hosted by EY. Jubaan is developing a none-invasive, AI imaging platform to detect GI disorders based on deep learning of images taken from the human tongue. The…

Read More
August 10, 2022

ד"ר שמעון אקהויז, יו"ר סופוייב, על רקע הסכם לשיתוף פעולה אסטרטגי של סופוויב עם HTDK, חברה סינית בבעלות קרן ההשקעות האמריקאית ורבורג פינקוס: "המשקיעים בסופוויב יראו הרבה פירות בהמשך"

היזם הסדרתי שמעון אקהויז, יוצא רפאל שעשה קריירה גדולה בתחום הרפואה האסתטית,  וחתום על ההצלחות של סינרון ולומניס בוול סטריט, הנפיק השנה אצלנו בתל אביב את סופווייב +16.22% שפועלת בתחום הפיתוח, שיווק וייצור טכנולוגיה לא-פולשנית לטיפולי הצערת ומיצוק העור. שווי ההנפקה היה 600 מיליון שקל וירד ל-377 מיליון כיום כשבדרך השווי עבר את ה-1 מיליארד שקל - הירידה לא מרגשת…

Read More
August 3, 2022

Butterfly Medical Announces First BPH Clinical Study Procedures Performed in North America

Butterfly Medical Announces First BPH Clinical Study Procedures Performed in North America for its Next Generation Minimally Invasive Solution First procedures were successfully performed under local anesthesia in an office setting by Steven Gange MD FACS, Summit Urology, Utah. Butterfly Medical, an Israeli medical device company developing a novel minimally invasive solution to treat Benign…

Read More
June 23, 2022

 SequelCare Health was selected to join the Margalit Startup City Haifa innovation program in the area of digital health

Proud to share that SequelCare Health (Peloton-Health), our portfolio is one of 8 companies selected, out of 100 leading companies applied, to join the Margalit Startup City Haifa innovation program in the area of digital health. The goal of the program is to identify technological companies at different stages that are developing innovative technology and to…

Read More
June 20, 2022

Meet our CEOs -  Yoni Epstein, Co-Founder and CEO of Anchora Medical Ltd.

We are excited to introduce you to Yoni Epstein, Co-Founder and CEO of our portfolio company Anchora Medical Ltd. , that developed a game changer automatic suturing platform for minimal invasive procedures. Yoni has over 20 years of experience in medical devices and Health care IT. He established 3 companies, 2 were acquired by large global companies.…

Read More
May 31, 2022

Filterlex Medical Announces Positive Results from A First-In-Human Study for the CAPTIS®

Filterlex Medical Announces Positive Results from A First-In-Human Study for the CAPTIS® Full-Body Embolic Protection Device Caesarea, Israel, May 31st, 2022 – Filterlex Medical Ltd., a cardiovascular medical device startup, announced today results from a first-in-human (FIH) study demonstrating the safety, feasibility, and performance of the CAPTIS device. CAPTIS is a next-generation, full-body embolic protection…

Read More
March 29, 2022

"התחום שלנו הופך אנשים למאושרים יותר, ורופאים לעשירים יותר, אמר לאחרונה ד"ר שמעון אקהויז, מחלוצי תעשיית האסתטיקה הרפואית

טכנולוגיות פורצות דרך הפכו את ישראל למובילה בשוק הסרת השיער והטיפולים בעור בתחילת המילניום, אבל בעשור האחרון רוב החברות הגדולות נמכרו והתעשייה המקומית כמעט לא נכנסה לתחום ההזרקות הצומח • עכשיו חברות הדור הבא מחפשות את הדרך לכבוש שוב את השוק העולמי • לבכירי התעשייה יש כמה רעיונות איך לעשות את זה "התחום שלנו הופך…

Read More
March 16, 2022

Sofwave (TASE:SOFW) benefits from the "zoom boom", shows growth in activity and concludes 2021 with revenues of $22 million

Sofwave (TASE:SOFW), a portfolio company of Alon MedTech Ventures, went public in the Tel Aviv Stock Exchange in May 2021, benefits from the "zoom boom", shows growth in activity and concludes 2021 with revenues of $22 million. https://lnkd.in/dfDUYrGG

Read More
March 7, 2022

Alon Medtech Ventures was part of 'Dubai-Israel: Future Horizons Mission' forum in Dubai

Assaf Mansour, Co-founder and partner at Alon MedTech Ventures and an active director in Sofwave (TASE:SOFW) and Michael (Miki) Eden , partner at Alon MedTech Ventures and an active director in Epitomee Medical (TASE: EPIT) were part of 'Dubai-Israel: Future Horizons Mission' forum hosted by the Dubai International Chamber. The forum was organized by Dubai International Chamber, the UAE Embassy in Israel and the Tel Aviv…

Read More
March 3, 2022

Happy to welcome Sequel Care to Alon Medtech Ventures

Happy to welcome Sequel Care to Alon Medtech Ventures. SequelCare, headed by Amir Nathan developing a new AI behavioral health care platform, to transform the way mental health care is delivered. As therapy is not one size fits all, SequelCare developed a platform for personalized and effective therapeutic treatment, managing and tracking patients' progress, identify patients at risk,…

Read More
March 2, 2022

Hallura Announces Successful Topline Results of European Multi-Site Clinical Trial with its New BiOLinkMatrix HA Aesthetic Dermal Fillers

YOKNEAM, Israel, March 2, 2022 /PRNewswire/ -- Hallura Ltd., an Israeli aesthetic medical company developing next generation Hyaluronic Acid (HA) Dermal Fillers with its proprietary BiOLinkMatrix platform, announced today successful topline results from its multi-site European clinical trial in three indications for lips enhancement, nasolabial folds correction and cheeks enhancement. The company's open-label, multi-center trial is evaluating the safety and…

Read More
February 27, 2022

Dr. Shimon Eckhouse, Alon’s Chairman and Epitomee Medical that had the honor to open trading on the Tel Aviv Stock Exchange

Happy to share the exciting morning for Dr. Shimon Eckhouse, Alon’s Chairman and Epitomee Medical that had the honor to open trading on the Tel Aviv Stock Exchange. Congratulations! Epitomee Medical (Tase: EPIT) developed a breakthrough weight management product based on the use of a device in a capsule that is swallowed by the user daily inducing safe and effective…

Read More
February 21, 2022

Meet HALLURA an aesthetic medical company developing the next generation of Hyaluronic Acid (HA) Dermal Fillers! 

Meet HALLURA our portfolio company, an aesthetic medical company developing the BiOLink Matrix platform - the next generation of Hyaluronic Acid (HA) Dermal Fillers! The patented BiOLinkMatrix technology is a new smooth crosslinking method that avoids the use of aggressive chemicals and is designed to create more natural, highly elastic, biodegradable and very safe HA dermal fillers.…

Read More
February 20, 2022

DR. Judith Zilberstein, our CEO will share her extensive experience in entrepreneurship, technology strategist and business experience at the digital 3rd Annual European HealthTech CEO Forum (EHTF)

We are proud and excited to share that DR. Judith Zilberstein, Alon MedTech Ventures CEO will share her extensive experience in entrepreneurship, technology strategist and business experience in medical technologies and private equity Israeli –start-up investment funds, as a speker in the digital 3rd Annual European HealthTech CEO Forum (EHTF), will take place on the 28th of February…

Read More
February 7, 2022

Welcome to David Hanuka as the CEO of GerdCare Medical

We are pleased to welcome David Hanuka as the CEO of GerdCare Medical, a portfolio company developing Electro-Stimulation Devices, for non-invasive treatment of Gastroesophageal Reflux Disease (GERD) a chronic disease. David established Stimatix GI and served as its CEO. Under his leadership the company was acquired by B.Braun. David is an entrepreneur, inventor and medical device industry…

Read More
February 2, 2022

 Judith Zilberstein our CEO, a speaker on IESE Women in Business Club 's WIB Conference

We are so excited to have Judith Zilberstein our CEO as a speaker on IESE Women in Business Club 's WIB Conference! on February 3, 2022 at 10am CET. This is a special opportunity to discuss, network and be inspired alongside 20+ leaders across industries and sectors that will discuss “The Future of Work: Maximizing the Impact of Women.”…

Read More
January 30, 2022

Dr. Shimon Eckhouse co-founder and chairman of Sofwave talks to Dr. W Grant Stevens, in the latest episode of the “Technology of Beauty”

Dr. Shimon Eckhouse co-founder and chairman of Sofwave, our portfolio company, talks to Dr. W Grant Stevens, in the latest episode of the “Technology of Beauty” about how he and his partners are revolutionizing the world of non-invasive wrinkle reduction treatments with Sofwave™, how it came to be, the technology behind it and why he thinks it will change…

Read More
January 20, 2022

ד"ר שמעון אקהויז, יו"ר אלון מדטק ונצ'רס אחד מהדמויות המשפיעות בענף ההלת'טק בישראל

היזם הסדרתי והמשקיע שמעון אקהויז הוא קטר שמוביל אחריו עשרות חברות טכנולוגיה רפואית, שרובן מגיעות לשלב ההנפקה או האקזיט בהצלחה משמעותית. אקהויז נולד באוקראינה וגדל במעברה בפרדס חנה. הוא גר בחיפה, נשוי ואב לשתי בנות ובן, כולם מנכ"לי חברות סטארט אפ משלהם. הוא למד לתואר ראשון ושני בפיזיקה בטכניון וב-1978 קיבל דוקטורט בפיזיקה מאוניברסיטת קליפורניה…

Read More
January 3, 2022

רשות החדשנות האירופית תשקיע 38 מיליון אירו בארבע חברות פרוטפוליו של אלון מדטק ונצ'רס.

הרשות תשקיע בחברות שבהן מושקעת אלון מדטק ונצ'רס, שמפתחות טכנולוגיות רפואיות בתחום הלב. על כספי ההשקעה, בהיקף 627 מיליון יורו, התמודדו 2,000 חברות, מתוכן זכו במימון 99 בלבד.   המימון לקרן של אקהויז יתחלק כאמור בין ארבע חברות: קרדיאק סאקסס (Cardiac Success), פילטרלקס (Filterlex), הליום מדיקל (Healium Medical) וטריסול מדיקל (Trisol Medical). קרדיאק סקסס תקבל…

Read More
December 30, 2021

Dr. Shimon Eckhouse, Alon's Chairman has been elected as Bizportal's Entrepreneurs Of The Year for 2021

We are excited and proud to announce that Dr. Shimon Eckhouse, Alon's Chairman has been elected as Bizportal's Entrepreneurs Of The Year for 2021. https://www.bizportal.co.il/capitalmarket/news/article/799498 

Read More
December 27, 2021

Filterlex Medical was selected to receive €7 Million of equity investment from the EIC

Amazing work by Sigal Eli, CEO and the Filterlex Medical Ltd. team! We are excited to share the great achievement of receiving equity investment from the European Innovation Council Accelerator. Filterlex Medical was selected to receive €7 Million of equity investment from the EIC. This follows recent closing of a US $6 Million series A1 investment round last…

Read More
December 21, 2021

Butterfly Medical received verification from the FDA approving IDE submission

Butterfly Medical received verification from the FDA approving IDE submission for the Butterfly study. This approval allows Butterfly to begin preparing for our Pivotal trial and plan for initial US procedures in early 2022! The FDA concluded that sufficient data was provided to support activation of a human clinical study in the US. The decision…

Read More
November 24, 2021

Butterfly Medical Receives CE Approval for its Next Generation Medical Device to Noninvasively Treat BPH Patients

Butterfly Medical, today announced that its next generation device to reduce or eliminate benign prostatic hyperplasia (BPH) symptoms has obtained European CE Mark approval. BPH is a condition where the prostate enlarges and is highly prevalent in men, 50+ years old. Its symptoms often include problems urinating, urgency to urinate, getting-up during the night, as…

Read More
November 21, 2021

Filterlex Medical Closes a $6Million Series A1 Investment to Accelerate the CAPTIS® Cardiovascular Clinical Program

Filterlex Medical, a cardiovascular medical device startup, announced today that it has recently completed a US $6 Million series A1 investment round from leading private investors in the healthcare sector. The financing will accelerate implementation of the company’s CAPTIS® clinical program. The CAPTIS® is a next-generation, full-body embolic protection device to reduce the risk of stroke and…

Read More
November 16, 2021

Sofwave™ Announces FDA clearance of New Lifting Indications for Eyebrow, Sub-Mental and Neck Facial Areas

The new indications include Eyebrow lifts and lifting of Lax tissue of the Submental and Neck Areas 80% of patients participating in a multi-site clinical trial saw improvement in just 12 weeks Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announces that the U.S. Food…

Read More
September 2, 2021

Approval to Market Sofwave™ in South Korea

Key Regulatory Milestone in Company’s International Growth Strategy for Unrivaled Ultrasound Technology Treating Fine Lines and Wrinkles YOQNEAM, Israel, Aug. 30, 2021 /PRNewswire/ — Sofwave Medical LTD, today announced it has received approval from the Korean Ministry of Foods and Drug Safety (MFDS) to market Sofwave™ its proprietary next-generation Synchronous Ultrasound Parallel Beam technology SUPERB™ for reducing the appearance of fine…

Read More
August 24, 2021

Shimon Eckhouse rides again with SofWave

Aesthetic medicine veteran Eckhouse (Lumenis, Syneron) explains what's new about SofWave and why it chose Tel Aviv for a flotation. This year, a new aesthetic medicine company was listed on the TASE, led by none other than Shimon Eckhouse, a pioneer in the field and considered the father of the industry. Eckhouse founded two of…

Read More
August 23, 2021

שמעון אקהויז מגיע לבורסה בתל אביב ומספר על התבגרות שוק האסתטיקה בישראל

ד"ר שמעון אקהויז, שאחראי להצלחות הגדולות של ישראל בתחום האסתטיקה הרפואית, הביא לאחרונה לבורסה בת"א את סופווייב, שפיתחה מוצר למיצוק והצערת העור • לאחר שהנפיק בעבר את החברות לומניס וסינרון מעבר לים, הוא טוען: "אנחנו קצת צעירים לנאסד"ק, ולכן אמרנו שאולי דווקא בת"א נקבל ערך אטרקטיבי, ואכן קיבלנו" השנה התווספה לבורסה חברה חדשה הפועלת בתחום…

Read More
July 12, 2021

Cherry Imaging offers a 3D facial scanning system that is set to transform the future of aesthetics

Cherry Imaging was FEATURED on GLAMURE UK article by SUZANNE BAUM: "Cherry offers a 3D facial scanning system that is set to transform the future of aesthetics.... a game-changer when it comes to analyzing your skin. And for those used to having Botox, fillers and other cosmetic injectables, the cherry imaging machine now provides an…

Read More
July 11, 2021

Anchora Medical Receives FDA clearance for its Su2ura® Minimally-Invasive Surgical Suturing Device.

Anchora Medical, an Israel-based medical device company, announced today that it has received 510(k) clearance from the United States (U.S.) Food and Drug Administration (FDA) to market its Su2ura® Approximation Device, an innovative, automated suturing device used in laparoscopic surgery, for the placement of interrupted or running stitches in soft tissue. Today, standard laparoscopic suturing during Minimal-Invasive…

Read More
July 5, 2021

Medical device startup Cardiac Success closes $5.2 million Series A

Proceeds will be used for pre-clinical testing and the completion of a First-in-Human trial of the company’s innovative “V-sling” heart failure therapy Cardiac Success, an Israel-based medical device company developing a transcatheter ventricular repair device for heart failure patients, has announced the closing of a $5.2 million Series A financing round. The round was led…

Read More
May 26, 2021

Sofwave Medical opened trading this morning in celebration of its IPO on TASE

Tel Aviv, May 26, 2021 - Management of Sofwave Medical opened trading this morning in celebration of its IPO on TASE. Sofwave Medical is one of the 44 new companies listed on TASE since the beginning of the year, raising an aggregate of NIS 5.1 billion. Sofwave Medical is included in TASE's Biomed Sector, which…

Read More
May 12, 2021

Butterfly Medical Appoints Medical Device Industry Leader, Steffen Hovard, to Board of Directors

Butterfly Medical Ltd., an Israeli medical company developing a novel implant for the prostate for the treatment of enlarged prostate (BPH) symptoms in aging men, today announced that it has appointed, medical device and urology industry leader, Mr. Steffen Hovard, to serve as an independent director of Butterfly Medical’s Board of Directors. Over the last…

Read More
March 25, 2021

באטרפליי מדיקל מציעה גישה חדשנית לטיפול בבעיית הערמונית המוגדלת

בעיית הערמונית המוגדלת נפוצה בקרב מרבית הגברים החל מהעשור השישי לחייהם, ומתבטאת בריצה תכופה לשירותים וקושי להתרוקן. הטיפולים המקובלים, תרופות או ניתוח, עלולים לפגוע באיכות חיי המין של המטופל. חברת באטרפליי מדיקל מציעה גישה שונה לטיפול, באמצעות שתל קטן, ללא חומרים כימיים ועם התאוששות מהירה. לכתבה המלאה: https://www.dmag.co.il/pub/paprika/Men's-Health/10/    

Read More
March 16, 2021

Elcam Medical invests $1.5 million in Serenno Medical for kidney monitoring device

Elcam Medical, an Israeli healthtech company that creates medical devices for monitoring fluid management in a variety of different medical fields will invest $1.5 in Serenno Medical, a local medical device startup and will manufacture Serenno’s urine output and intra-abdominal pressure digital monitoring device, Sentinel. The device is designed to detect acute kidney injuries (AKI),…

Read More
January 13, 2021

יזמות בטכנולוגיה רפואית: האתגרים וההזדמנויות - ד"ר שמעון אקהויז, ספר ההייטק הישראלי 2020

מה גורם ליזמויות להצליח ומדוע לא מעטות מהן נכשלות? ד"ר שמעון אקהויז, יזם, ממציא ומשקיע, שהיה מעורב בהקמת כ-30 חברות, רובן בתחום הרפואי, מפרט אילו תכונות אופי נדרשות ליזמים ומה משפיע על סיכויי ההצלחה של המיזם ועל הסיכוי של היזמים לגייס לו השקעה https://www.themarker.com/labels/hitech/medical/1.9431860  

Read More
January 5, 2021

Butterfly was featured on "Tennessee Tribune"

Medical Coil Treats Enlarged Prostate Without Surgery or Drugs Half of men over age 51 — and 90% of men over 80 — suffer from non-cancerous benign prostatic hyperplasia (BPH). That means they have trouble urinating because of an enlarged prostate. Butterfly Medical has developed an innovative metal coil, shaped roughly like a butterfly, to stop…

Read More
October 7, 2020

Butterfly Medical closed its $7M B round, Leading the round is New Rhein, a US based healthcare focused fund.

We are happy to update that Butterfly Medical, one of our portfolio companies at Alon Medtech Ventures closed its $7M B round. Leading the round is New Rhein, a US based healthcare focused fund. Butterfly Medical successfully completed the enrollment of 49 patient to its multi-center clinical study testing the company’s novel implantable device in patients…

Read More
July 2, 2020

Hallura announces the appointment of Paul Navarre to its Board of Directors

Hallura Ltd., an Israeli aesthetic medical company developing the next generation of Hyaluronic Acid (HA) Dermal Fillers, today announced that it has appointed Mr. Paul Navarre to serve as an independent director of Hallura’s Board of Director. “We are excited to welcome Mr. Paul Navarre as he brings a wealth of knowledge and experience to…

Read More
March 1, 2020

Anchora Medical announces closing of a $4.5M financing round led by HOYA Corporation

Anchora Medical is developing a single-use suturing device for the approximation of soft tissue during Minimally Invasive Surgery (MIS) Anchora Medical, a portfolio company of Alon Medtech Ventures, announced today closing of a $4.5 million financing round led by HOYA Corporation (ADR: HOCPY, TYO: 7741), a key strategic investor, and Tal Capital. The funds will…

Read More
January 29, 2020

Butterfly Medical completes a $2M round of financing

This round was led by Paul Merage and Kamran Siminou private investors from the US, Mori Arkin and Dan Susskind from Israel and several other private investors. The funds will be used for the expansion of the clinical trial in Israel and the launch of a pivotal clinical trial in the US. The company has…

Read More
January 27, 2020

Serenno Medical successfully concludes first human clinical study

Serenno Medical developing an innovative and robust medical device for automatically monitoring and detecting kidney damage in hospitalized patients, giving the medical staff early warning and allowing for an effective and minimal intervention when needed. Ongoing kidney function assessment is enabling the medical staff to detect and avoid a common and life-threatening danger - Acute…

Read More
January 8, 2020

Sofwave Medical and Cherry Imaging two of the top 5 Pioneering Companies in the Aesthetic field Standing Out for Innovation

Sofwave Medical and Cherry Imaging were tagged as two of the top 5 Pioneering Companies in the Aesthetic field Standing Out for Innovation. https://lnkd.in/dwCw-34

Read More
December 12, 2019

Healium Medical won the 1st prize of the ICI 2019 Innovation Award

Healium Medical, a portfolio company of Alon Medtech Ventures, is a medical device start-up developing the world’s first stand-alone, non-contact guided ultrasound ablation for pulmonary vein isolation with integrated lesion monitoring capabilities. The company’s solution consists of an over-the-wire catheter with a propriatery ultrasound transducer positioned within the pulmonary vein ostium for rapid, non-contact circumfrential…

Read More
November 18, 2019

Hallura, a Portfolio Company of Alon MedTech Ventures, Closes Its $7M Financing Round

The round was led by a group of US, Europe and Israel-based investors; Proceeds will be used to complete its clinical trials and register its breakthrough proprietary Hyaluronic Acid Dermal Fillers in Europe Hallura Ltd., an Israeli based aesthetic medical company developing a new generation of Hyaluronic Acid (HA) Dermal Fillers, closes its A round…

Read More
September 23, 2019

The European Commission Horizon 2020 Program Backs Filterlex's Embolic Protection Device - CAPTIS

Filterlex Medical, an innovative medical device startup in the cardiovascular field, today announced that the company has been selected for the Phase 2 Horizon 2020 SME Instrument program. The SME Instrument program awards financial support to companies that demonstrate world class technology innovation, a sound business plan and great promise in becoming a high growth company.  …

Read More
September 15, 2019

Butterfly Medical won the MassChallenge Israel 2019, and was awarded a Diamond winner reward of 200K ILS

Butterfly Medical, a portfolio company of Alon Medtech, was announced as one of the Israeli start-ups that won the MassChallenge Israel 2019, and was awarded a Diamond winner reward of 200K ILS. Butterfly Medical is developing a non-surgical implant to treat the symptoms of an enlarged prostate (BPH).     https://www.linkedin.com/posts/masschallenge-israel_masschallenge-israel-awards-500000-ils-in-activity-6578125396707942400-Eu2t/

Read More
August 7, 2019

SofWave, portfolio company of Alon Medtech, closes $8.4M financing round. Announces appointment of Louis Scafuri to CEO position

Round led by XT Hi-Tech, an Israeli-based VC and a group of Israel and US-based investors. Proceeds will be used to commercialize its proprietary Fractional Ultrasound Technology product for skin tightening and wrinkle treatment SofWave Ltd., portfolio company of Alon Medtech, an Israeli based Aesthetic medical company developing Non-Invasive Fractional Ultrasound Technology for skin tightening,…

Read More
July 21, 2019

Filterlex Medical won the best innovation award at the EuroPCR 2019

Filterlex was awarded $200,000 prize by the Jon DeHaan Foundation Filterlex Medical is a medical device start-up company, developing an innovative embolic protection device (CAPTIS) for reducing the risk of stroke and other complications during catheter-based structural heart procedures. CAPTIS, which provides an exciting breakthrough for TAVR patients, won best innovation award at the prestigious…

Read More
July 21, 2019

Filterlex Medical Raised $3M in Series A Financing

Filterlex won the best innovation award at the EuroPCR 2019 conference in Paris and was awarded $200,000 prize by the Jon DeHaan Foundation. Filterlex Medical is a medical device start-up company, developing an innovative embolic protection device (CAPTIS) for reducing the risk of stroke and other complications during catheter-based structural heart procedures. The company recently…

Read More
June 15, 2019

Dr. Shimon Eckhouse was a Keynote Speaker in Israel Medical Aesthetics Industry Forum in Chengdu, China

Dr. Eckhouse was invited by the Economic and Trade Mission to Southwest China, the Consulate General of Israel in Chengdu, as a keynote speaker at The 2nd International Aesthetic Industry Conference will be held in Chengdu on June 15-17, 2019. The event, held for the second year, enjoys the support of Chengdu local government authorities…

Read More
April 28, 2019

Anchora Medical CEO, Yoni Epstein presented at the SAGES convention Baltimore, April 2019

Anchora Medical CEO, Yoni Epstein presented the company's Approximation Device at the SAGES convention Baltimore, April 2019. The Anchora Approximation Device is a unique, sterile single-use device for the approximation of soft tissue during minimally invasive surgeries (MIS), such as hernia repair. The device incorporates tiny stainless steel anchors threaded on a surgical thread creating…

Read More
March 6, 2019

NeuroIndex presented at the 4th International BrainTech 2019, in Tel Aviv

Leon Boston CEO & Co-founder of NeuroIndex presented at the 4th International BrainTech 2019, held in Tel-Aviv on March. NeuroIndex was selected as one of the 5 finalists of the BrainTech 2019 Startup Competition. NeuroIndex is developing an intraoperative brain monitoring device for anesthesiologists that offers real-time insight and alert , to brain injury during…

Read More
February 24, 2019

Cherry Imaging to launch its novel aesthetic imaging technology at the AAD, on Feb 28

Cherry’s Imaging handheld scanner enables scientific data measurements for accurate, objective, and traceable aesthetic and medical treatments on both face and body Tel Aviv, Israel, Feb. 25, 2019 - Cherry Imaging, a leading developer of high-resolution scanner for aesthetic applications on both face and body will launch its cutting-edge technology at the AAD (American Academy of Dermatology)…

Read More
February 1, 2019

Cherry Imaging won 1st prize at the IMCAS Innovation Shark Tank in Paris

Cherry presented its cutting edge technology at the IMCAS Innovation Shark Tank that was held in Paris on February. The forum gives entrepreneurs the opportunity to showcase their innovations and present to a unique audience made of industry leaders, venture-capitalists and physician Key Opinion Leaders. Cherry™ presented alongside 15 innovative startups in the medical space and awarded…

Read More
December 26, 2018

Multicentral clinical trial of Butterfly’s retraction system was launched in Israel

Initial 3 patients enrolled into a trial with Butterfly’s retraction system and treated in Ziv Hospital (Safed) by the Chief of Urology Department, Dr. Ran Katz and his team. Each minimally invasive procedure duration for BPH (Enlarged Prostate) was about 10 minutes and the patients were released from the Medical Center rapidly. The quality of patient’s…

Read More
October 15, 2018

Trisol Medical, a portfolio company of the Alon MedTech Ventures, raises $2.7m

Trisol, which has developed a minimally invasive way to replace the tricuspid heart valve, is aiming at a $6 billion market

Read More
October 10, 2018

Butterfly Medical opens first clinical trial site in Israel

The Israeli Ministry of Health granted Butterfly Medical the approval to conduct clinical trials in Israel. The first patient was enrolled at Ziv Medical Center. This patient, who suffered from BPH symptoms, reported significant improvement in symptoms at his 2-week follow-up visit. Several other medical centers in Israel are currently in process to join this…

Read More
July 10, 2018

First patient completes 18 months with the Butterfly Medical device

First patient completes 18 months with the Butterfly device. The 83 year-old patient suffered from severe symptoms associated with BPH (enlarged prostate), affecting his ability to urinate and needed to use a permanent catheter for the 2 years prior to joining the Butterfly Medical clinical trial. The Butterfly procedure took 10 minutes and was done under…

Read More
April 12, 2018

Anchora Medical announced winner of the i3 summit shark tank competition at the 2018 SAGES 

Anchroa Medical has won the i3 summit shark tank competition at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and was elected 1st place by both the judges chaired by Dr. Mike Kochman and Dr. Jeffrey Marks and the audience comprised of surgeons and medical device industry players.

Read More
November 28, 2017

Butterfly Medical awarded CE Mark for prostate device

Israeli medical device company Butterfly Medical today announced that its novel medical device for non-surgical, office-based treatment of Benign Prostate Hyperplasia (BPH), has obtained European CE Mark approval. BPH or enlarged prostate affects about 105 million men globally ?- more than 4 out 10 men over the age of 50 . Its symptoms often include…

Read More
September 28, 2017

Butterfly Medical publishes an interview with a user of the Butterfly device and with his physician

Butterfly Medical publishes an interview with a user of the Butterfly device and with his physician: https://www.youtube.com/watch?v=k-86PdxrZHY&feature=youtu.be 

Read More
April 9, 2017

Butterfly Medical wins 2nd place at LAUNCH, the UC Berkeley Startup Accelerato

Butterfly Medical wins 2nd place at LAUNCH, the UC Berkeley Startup Accelerato

Read More
March 20, 2016

Alon MedTech Ventures signed a cooperation agreement with Tsinghua University

The Alon MedTech Ventures incubator, established by chairman Dr. Shimon Eckhouse and CEO and CTO Dr. Judith Zilberstein, is signing a cooperation agreement with Tsinghua University, considered one of China's leading universities. This is the first cooperation agreement of its kind between an Israeli technology incubator and a Chinese entity. The agreement is Tsinghua University's…

Read More
  • Home
  • About
  • Team
  • News
  • Contact Us

CONTACT US

YOKNEAM

ZIP CODE 20692 ISRAEL

TEL:+972-4-6432991

OFFICE@ALON-MEDTECH.COM

© 2026. Alon MedTech Theme. All Rights Reserved. Design by Yomiko Digital

Renaly

Renaly develops therapeutic neuromodulation ultrasound technology addressing the unmet clinical need of patients suffering from uncontrolled and resistant hypertension.

Supra

SUPRA develops an in-office guided ophthalmic injector.
Its unique design provides a safe and intuitive access to the sub choroidal space to allow new drugs administration.

Serenno Medical

Pioneering Urine-Output (UO) Measuring Device for the ICU

A breakthrough solution for accurate and automatic UO measurement, with lower cost, less workload and improved patient safety.

GerdCare Medical

Electro-Stimulation Devices, for non-invasive treatment of Gastroesophageal Reflux Disease (GERD) a chronic disease.

Website

Cardiac Success

A Transcatheter Cardiac Implant Focused on Improving Ventricular Geometry

Developing a novel transcatheter cardiac implant to improve cardiac function in patients with heart failure and/or functional mitral regurgitation.

Website

Sequel Care

Enhance mental health caregiving with collaborative, evidence based, and action-focused care platform.

Website

Levron Cardiovascular

Developing a novel autonomic integrated diagnostic and therapeutic device used to treat heart failure patients reducing hemodynamic and lung congestions, alleviating dyspnea and improving cardiac loading conditions.

 

Excita

A new approach to Electric Muscle Stimulation for body sculpting devices – introducing personalized adaptive treatments to the body shaping market.

Cherry Imaging

A full software and hardware solution for image management in aesthetic clinics and using it for marketing and patient retention.

Website

Jubaan

An oral imaging device to screen and detect colon cancer and additional GI diseases using deep learning and big data analysis. The Jubaan  device can replace the ineffective fecal blood testing currently used for early detection of Colon cancer

Website

NeuroIndex

EEG measurement device and algorithms analyzing brain health during major surgical procedures avoiding long term brain damage and POCD (Post Operative Cognitive Deterioration) following deep anesthesia.

Dr. Shimon Eckhouse

Active Chairman

Dr. Eckhouse is the founder, owner and Chairman of Alon Medtech.

An inventor, active entrepreneur and investor in the field of medical devices and medical technology,

Until July 2017 Dr. Eckhouse was the chairman of Syneron Medical Ltd. (Nasdaq ELOS) which he co-founded in 2001, until it was acquired by APAX partners.

Dr. Eckhouse is the chairman and co-founder of Epitomee medical, Rapid Medical, Theranica, RealView. Dr. Eckhouse was a co-founder, chairman and CEO of ColorChip from 2001 to 2003; Was a co-founder of Ventor Medical Technologies and its Chairman until it was acquired by Medtronic in 2009 for $325M

Dr Eckhouse was the founder, chairman and CEO of Lumenis (former ESC) from its inception in 1992 until 1999. He took the company public on Nasdaq in 1996 and raised more than $250M in 3 public offerings, the company reached a valuation of more than $1B returning to its investors more than X120 on their investment in the company.

Dr Eckhouse is the inventor of IPL (Intense Pulsed Light) technology which he brought to market in 1994 in ESC and is the most popular non-invasive energy based technology for a broad range of non-invasive medical aesthetic applications.

Dr Eckhouse holds a BSc in physics from the Technion – Israeli Institute of Technology and a Ph.D. in physics from the University of California at Irvine. He is the author of more than 60 US registered patents and a few hundred international patents and published more than 50 papers in leading refereed journals and conferences.

    

Assaf Mansour

VP Business Development

Mr. Mansour is a co-founder of Alon Medtech.

Assaf brings extensive experience and expertise in investments due diligence, examines the commercial feasibility,  strategic planning, management and business development.

Assaf maintains a long-term commitment to the portfolio companies by working closely with the entrepreneurs and assisting them with business development and keep supporting them after they have become independent and successful companies

Mr. Mansour is serving as an active board member in Sofwave Medical (TASE:SOFW) and several more medical companies.

Prior to founding Alon Medtech, Mr. Mansour worked in high-tech companies for more than 12 years’, with particular expertise in managing international customers. In his last positions he served as account program manager at Comverse and TTI Telecom, where he was responsible for customers across North America and Europe..

Mr. Mansour holds a BSc in Industrial Engineering and an MBA from the Ben-Gurion University of the Negev.

    

Michael (Miki) Eden

CFO

Mr. Eden has joined Alon Medtech as Chief Financial Officer in 2014.  He has over 20 years of experience in VC’s investments and management of high growth technology companies.

Miki has vast experience in M&A and IPO transactions, fund raising, due diligence processes, post-acquisition integration and active management and control over global subsidiaries. Prior to joining Alon Medtech, Michael  served as a Financial, Commercial and Operational executive in leading high-growth technology companies such as: Convergin, a provider of service broker platforms to mobile operators, acquired by Oracle;  Hobart (Prof Shlomo Ben Haim’s investment group) specializing in active management of its health-care portfolio companies from seed stage through acquisition and IPOs; and Aura Investment a publicly traded investment company focused on early stage investments and active management of technology companies.

Michael has a B.A in accounting and business administration and a Master of Law (LL.M) from Bar Ilan University and is also an Israeli certified public accountant.

miki@alon-medtech.com

Haya Anuka

Marketing Director

Haya works closely with the Alon Medtech Chairman, CEO and management team on business intelligence and Marketing strategy, managing all marketing activities of Alon.

Prior to Alon Medtech, Haya was Marketing Manager leading  strategy, budget and execution at a prominent IT integration company; Account manager at a leading PR firm; and Legal intern at Herzog Fox & Neeman – Capital Markets and Securities Dep, worked with public companies in all Corporate and Securities Law matters, engaged in public and private offerings of securities, worked on M&A transactions.

Haya holds an LLB degree form Kiryat Ono Academic College.

    

Dr. Ruthie Amir

Chief Medical Officer

Dr. Ruthie Amir joined Alon Medtech Ventures as the chief medical officer in 2018.

Prior to joining Alon Medtech Dr. Amir served as the director of clinical research and the head of the regulatory department of Syneron Candela from 2008 to 2017.

Dr. Ruthie Amir graduated from Ben Gurion University Medical School in 1989. From 1996-2000, she completed her post-doctoral fellowship in the Department of Human Genetic, at Baylor College of Medicine, Houston, USA where she worked on the genetic basis of Rett Syndrome. Between 2000-2003 she completed a post-doctoral fellowship in the Department of Cell Biology, Faculty of Medicine, Technion.

 

    

Dr. Judith Zilberstein

CEO and CTO

Dr Zilberstein is responsible for managing Alon Medtech, including choosing projects, advancing them into companies and guiding their scientific activity.

Dr Zilberstein leads  the marketing strategy together with the companies and forges scientific and commercial ties with external groups. She serves as a board member in the portfolio companies of Alon MedTech.

Dr Zilberstein has more than 20 years’ experience in the medical device industry; Vast experience in investments in the Healthcare and nanotech fields.

She served as GM of Maayan Ventures, an early stage investment fund; an active director/chairperson of numerous early stage companies; CTO & BDD of several entrepreneurial medical oriented companies and technological incubators.  Dr Zilberstein is the inventor of a several innovations, in the field of optical sensors and cancer therapy.

Dr Zilberstein holds a BSc in chemistry. MSc in chemical physics and PhD in life science, from the Weizmann Institute of Science, She has published numerous scientific articles.

 

    

Filterlex

Next-generation embolic protection device for transcatheter aortic valve implantation (TAVI)

The Filterlex embolic protection device is a filter covered Nitinol frame and filter pockets. Its unique structure diverts embolic particles in the aortic arch to the capturing part of the device, where they remain and are extracted with the device at the end of the procedure.

Website

Hallura

Superior Dermal Fillers Using a Novel HA Crosslink

Hallura’s products are based on a radically new HA crosslinking technology, characterized by a low concentration of HA, very low crosslinking rates, and very high molecular weight of the HA chains, with no low molecular weight fragments.

Website

Healium Medical

Non-contact Atrial Fibrillation ablation therapy with real-time procedure monitoring

Developing the world’s first stand-alone, non-contact guided ultrasound ablation for pulmonary vein isolation with integrated lesion monitoring capabilities. The company’s solution consists of an over-the-wire catheter with a propriatery ultrasound transducer positioned within the pulmonary vein ostium for rapid, non-contact circumfrential ablation with real-time lesion feedback capabilities.

Website

SofWave

Innovating Non-Invasive Skin Tightening With USBT™

Developed a unique platform for non-invasive skin treatment: Ultrasound Beam Technology – USBT™, distinctive from any other ultrasound technology on the market.  An array of ultrasound transducers generates multiple beams of high frequency, high intensity ultrasound energy that penetrates into the skin with minimal divergence such that the energy doesn’t “spread out” as the beams penetrates into the tissue.

Website

Dr. Adina Makover

Advisory Board

For the past twelve years Dr. Makover has managed venture capital investments in the biotech/ medical devices field (Tzina Bio-Perspective, Proseed VC). Previously she held senior management positions in life sciences companies focusing on drugs, diagnostics and tissue engineering.

Dr Makover holds a joint Ph.D degree in life sciences from Columbia University (USA) and Weizmann Institute of Science, (Israel) and did post- doctoral research at the Weizmann Institute in Israel. DR. Makover also holds an MBA degree from Bar-Ilan University.

Dr. Makover is serving as a director of the board of six companies including public traded ones.

Prof. Asher Barzilai

Advisory Board

Prof Asher Barzilai was a director at the Edmond and Lily Safra Children’s Hospital at the Chaim Sheba Medical Center at Tel HaShomer, between 2011-2019. Prof Barzilai, an expert in infectious diseases, is an associate clinical professor of pediatrics at Tel Aviv University’s Sackler Faculty of Medicine.

Prof Barzilai earned his MD from Tel Aviv University, Israel. He specialized in Pediatrics at Mt. Sinai Hospital in New York City. Prof Barzilai holds an MBA from the executive MBA program run jointly by Northwestern and Tel Aviv Universities.

 

Prof. Asher Barzilai

 

Prof Asher Barzilai was a director at the Edmond and Lily Safra Children’s Hospital at the Chaim Sheba Medical Center at Tel HaShomer, between 2011-2019. Prof Barzilai, an expert in infectious diseases, is an associate clinical professor of pediatrics at Tel Aviv University’s Sackler Faculty of Medicine.

Prof Barzilai earned his MD from Tel Aviv University, Israel. He specialized in Pediatrics at Mt. Sinai Hospital in New York City. Prof Barzilai holds an MBA from the executive MBA program run jointly by Northwestern and Tel Aviv Universities.

 

Butterfly Medical

An innovative, implantable device for the treatment of Benign Prostatic Hyperplasia (BPH)

Developing a new generation device that offers a superior alternative to existing BPH minimally invasive treatments. Unlike current treatments that are surgical in nature and therefore require certain level of recovery and carry a risk of complications, the Butterfly Medical device is non-surgical, can be delivered at the comfort of the physician’s office and offers immediate relief.

Website

Anchora Medical

Next generation continuous endoscopic suturing for minimally invasive surgical procedures

Developing a novel atraumatic, non-ischemic continuous suturing device. The first surgical “sewing machine” for minimally invasive surgery, combining simplicity, strength and durability. A single action, automatic device that generates continuous laparoscopy / flexible endoscopy sutures based on threaded smart anchors whose unique design avoids ischemia and reduces tension on the tissue.

Website

Michael (Miki) Eden

CFO

Michael joined Alon Medtech as Chief Financial Officer in 2014.  He has over 20 years of management experience in overall financial & commercial strategy, fund raising and capital allocation, M&A transactions, investor relations,  governance and risk management. Michael is a Senior executive with vast experience in investing and managing high-growth technology companies, due diligence processes, post-acquisition integration and active management and control over global subsidiaries. He has extensive knowledge of business, legal and tax aspects relating to investments, management and control of portfolio companies in different fields.

Prior to joining Alon Medtech, Michael  served as a Financial, Commercial and Operational executive in leading high-growth technology companies such as: Convergin, a provider of service broker platforms to mobile operators, acquired by Oracle;  Hobart (Prof Shlomo Ben Haim’s investment group) specializing in active management of its health-care portfolio companies from startup stage through acquisition and IPOs; and Aura Investment a publicly traded investment company focused on early stage investments and active management of technology companies.

Michael has a B.A in accounting and business administration and a Master of Law (LL.M) from Bar Ilan University and is also an Israeli certified public accountant.

    

Anat Rosenthal

Director of Finance

Anat is overseeing the portfolio companies financial aspects including accounting, budget and tax. Anat has over 10 years experience in providing professional services across a broad range of finance areas.

Prior to Alon MedTech, Anat held senior finance positions for international cooperations, privately-held companies and Hi-Tech companies and also served as a professional department manager for over 8 years.

Anat is an Israeli certified public accountant and holds a B.A in Business Administration and Accounting and a M.B.A (Tax specialization) from the College of Management.

    

Etel Ackerman Pohoriles

General Counsel

Handling all legal aspects of Alon Medtech Ventures and its portfolio companies including fundraising, corporate law, labor law, clinical trials, commercial transaction, regulatory review as well as advising board of directors and C level executives on ongoing day-to-day issues.

Etel has over 13 years of legal counseling experience starting from commercial litigation through in-house counseling.

Etel holds LL.B from The Interdisciplinary Center in Herzliya and LL.M from the Tel Aviv Berkeley Executive program.

    

Judith Gal

Advisory Board

Experienced Chief Executive Officer with a demonstrated history of working in the medical device industry and Pharma industry. Skilled in the Cardio Vascular, Neurosurgery, Spine, Minimal invasive surgeries, Medical Devices, High Tech Home Care businesses.  Strong background in strategy and business development in the Medtech and Biotech industry.

Judith currently serves as a board member at a number of startups. She is a partner at HM Medical Solution LTD.

Judith has been until recently Medtronic’s Israel CEO for more than 12 years and an executive management member of Medtronic BCEGI region. Before joining Medtronic, Judith held senior management positions at Teva Ltd

 

Advisory Board

Dr. Adina Makover

For the past twelve years Dr. Makover has managed venture capital investments in the biotech/ medical devices field (Tzina Bio-Perspective, Proseed VC). Previously she held senior management positions in life sciences companies focusing on drugs, diagnostics and tissue engineering.

Dr Makover holds a joint Ph.D degree in life sciences from Columbia University (USA) and Weizmann Institute of Science, (Israel) and did post- doctoral research at the Weizmann Institute in Israel. DR. Makover also holds an MBA degree from Bar-Ilan University.

Dr. Makover is serving as a director of the board of six companies including public traded ones

    

ClipTip Medical

Develops novel micro clip applier devices for performing regular and advanced micro-laparoscopy

Our multi-clip devices are characterized by a diameter of less than 3 mm, longer clips; larger opening of the clip arms; better visibility of the clip and a secure closure. These features will render our devices superior over existing clip appliers and will make them an ideal tool for both, regular as well as advanced laparoscopy or endoscopy procedures such as: needlescopic surgery; single port surgery; NOTES; and robotic surgery.

Trisol Medical

A Transcatheter Tricuspid Valve Replacement (TTVR)

The Trisol valve is constructed out of nitinol frame with specially designed sail-like leaflet. Its unique design provides a comprehensive solution to Tricuspid Regurgitation and RV dysfunction.

Website

Judith Gal

Advisory Board

Experienced Chief Executive Officer with a demonstrated history of working in the medical device industry and Pharma industry. Skilled in the Cardio Vascular, Neurosurgery, Spine, Minimal invasive surgeries, Medical Devices, High Tech Home Care businesses.  Strong background in strategy and business development in the Medtech and Biotech industry.

Judith currently serves as a board member at a number of startups. She is a partner at HM Medical Solution LTD.

Judith has been until recently Medtronic’s Israel CEO for more than 12 years and an executive management member of Medtronic BCEGI region. Before joining Medtronic, Judith held senior management positions at Teva Ltd